← Back to Clinical Trials
Recruiting NCT07488325

NCT07488325 Multimodal Assessment of Malignancy in Atypia of Undetermined Significance in Thyroid Nodules Using Ultrasound and Cytology Whole-Slide Images

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07488325
Status Recruiting
Phase
Sponsor Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Condition Thyroid Nodule
Study Type OBSERVATIONAL
Enrollment 396 participants
Start Date 2026-03-01
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type OBSERVATIONAL
Interventions
Histopathology or cytopathology.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 396 participants in total. It began in 2026-03-01 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The prospective study aim to develop a multimodal deep learning model that integrates ultrasound images and cytological whole-slide images for more accurate malignant risk prediction of Bethesda III thyroid nodules.

Eligibility Criteria

Inclusion Criteria: * (a) Patients who underwent fine-needle aspiration of thyroid nodules and received a cytological diagnosis of Bethesda Ⅲ. * (b) Patients who subsequently underwent thyroid surgery with a definitive histopathological diagnosis of benign or malignant lesions,. * (c) Availability of at least one ultrasound image acquired prior to surgery. Exclusion Criteria: * (a) Patients without confirmation by surgical pathology,. * (b) Patients without any available or usable ultrasound images.

Contact & Investigator

Central Contact

Jingliang Ruan, Ph.D.

✉ ruanjl3@mail.sysu.edu.cn

📞 +8613694202230

Principal Investigator

Jingliang Ruan, Ph.D.

PRINCIPAL INVESTIGATOR

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Frequently Asked Questions

Who can join the NCT07488325 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Thyroid Nodule. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07488325 currently recruiting?

Yes, NCT07488325 is actively recruiting participants. Contact the research team at ruanjl3@mail.sysu.edu.cn for enrollment information.

Where is the NCT07488325 trial being conducted?

This trial is being conducted at Guangzhou, China.

Who is sponsoring the NCT07488325 clinical trial?

NCT07488325 is sponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. The principal investigator is Jingliang Ruan, Ph.D. at Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. The trial plans to enroll 396 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology